Investor Relations

Berlirem is currently seeking business cooperation with potential investors for clinical development and worldwide marketing of our patented product and our platform technology in CNS indications.

If you’re interested, we would be happy to provide you with a condensed business offer, or please feel free to contact us directly.

Berlirem GmbH

Königin-Luise-Str.27
14195 Berlin

Actually:
c/o M. Bräutigam
Droysenstrasse 8
10629 Berlin
Germany

Telefon: +49(0)30 288 69 878
Telefax: +49(0)30 288 69 696

Mobil: +49 (0)1755 755 291
E-Mail: m.braeutigam@berlirem.com